Proteins as T cell antigens: Methods for high-throughput identification

Vaccine

Volumn 31, Issue 37, 2013, Pages 3805-3810

  Grubaugh, Daniel ^a   Flechtner, Jessica Baker ^b   Higgins, Darren E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Cambridge Discovery Park   (United States)

Author keywords

High throughput screening; Protein antigen; Reverse vaccinology, MHC; Subunit vaccine; T cells

Indexed keywords

DNA VACCINE; INTERLEUKIN 17; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE VACCINE; SUBUNIT VACCINE; T LYMPHOCYTE ANTIGEN;

ADAPTIVE IMMUNITY; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ANTIGENICITY; CELLULAR IMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES SIMPLEX VIRUS; HIGH THROUGHPUT SCREENING; HOST PATHOGEN INTERACTION; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; OPEN READING FRAME; PEPTIDE LIBRARY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TARGETING; PROTEOMICS; REVIEW; VACCINIA VIRUS;

HIGH-THROUGHPUT SCREENING; PROTEIN ANTIGEN; REVERSE VACCINOLOGY, MHC; SUBUNIT VACCINE; T CELLS;

ANIMALS; ANTIGENS; HIGH-THROUGHPUT SCREENING ASSAYS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNITY, CELLULAR; PEPTIDE LIBRARY; PROTEINS; T-LYMPHOCYTES;

EID: 84881554917     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.046     Document Type: Review

References (46)

1. Fleischmann R.D., Adams M.D., White O., Clayton R.A., Kirkness E.F., Kerlavage A.R., et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 1995, 269:496-512.
2. Sette A., Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 2010, 33:530-541.
3. Davies D.H., Liang X., Hernandez J.E., Randall A., Hirst S., Mu Y., et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:547-552.
4. Ottenhoff T.H., Kaufmann S.H. Vaccines against tuberculosis: where are we and where do we need to go?. PLoS Pathogens 2012, 8:e1002607.
5. Mellman I., Coukos G., Dranoff G. Cancer immunotherapy comes of age. Nature 2011, 480:480-489.
6. Brunham R.C., Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nature Reviews Immunology 2005, 5:149-161.
7. Liu J., Zhang S., Tan S., Zheng B., Gao G.F. Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development. Experimental Biology and Medicine 2011, 236:253-267.
8. Rosa D.S., Ribeiro S.P., Cunha-Neto E.C.D4+ T cell epitope discovery and rational vaccine design. Archivum Immunologiae et Therapiae Experimentalis 2010, 58:121-130.
9. Lundegaard C., Lund O., Buus S., Nielsen M. Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology 2010, 130:309-318.
10. Pamer E.G. Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope. Journal of Immunology 1994, 152:686-694.
11. Karunakaran K.P., Rey-Ladino J., Stoynov N., Berg K., Shen C., Jiang X., et al. Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia. Journal of Immunology 2008, 180:2459-2465.
12. Parker D.C. T cell-dependent B cell activation. Annual Review of Immunology 1993, 11:331-360.
13. Shen H., Miller J.F., Fan X., Kolwyck D., Ahmed R., Harty J.T. Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell 1998, 92:535-545.
14. Wang L.X., Huang W.X., Graor H., Cohen P.A., Kim J.A., Shu S., et al. Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells. Journal of Translational Medicine 2004, 2:41.
15. Jing L., Haas J., Chong T.M., Bruckner J.J., Dann G.C., Dong L., et al. Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. The Journal of Clinical Investigation 2012, 122:654-673.
16. Tscharke D.C., Karupiah G., Zhou J., Palmore T., Irvine K.R., Haeryfar S.M., et al. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. The Journal of Experimental Medicine 2005, 201:95-104.
17. Valentino M.D., Abdul-Alim C.S., Maben Z.J., Skrombolas D., Hensley L.L., Kawula T.H., et al. A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens. Journal of Immunological Methods 2011, 373:111-126.
18. Jing L., Schiffer J.T., Chong T.M., Bruckner J.J., Davies D.H., Felgner P.L., et al. CD4 T-cell memory to viral infections of humans shows pronounced immunodominance independent of duration or viral persistence. Journal of Virology 2012.
19. Moron G., Dadaglio G., Leclerc C. New tools for antigen delivery to the MHC class I pathway. Trends in Immunology 2004, 25:92-97.
20. Fling S.P., Sutherland R.A., Steele L.N., Hess B., D'Orazio S.E., Maisonneuve J., et al. CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:1160-1165.
21. Jing L., Chong T.M., McClurkan C.L., Huang J., Story B.T., Koelle D.M. Diversity in the acute CD8 T cell response to vaccinia virus in humans. Journal of Immunology 2005, 175:7550-7559.
22. Starnbach M.N., Loomis W.P., Ovendale P., Regan D., Hess B., Alderson M.R., et al. An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+ T cell response. Journal of Immunology 2003, 171:4742-4749.
23. Hondowicz B.D., Schwedhelm K.V., Kas A., Tasch M.A., Rawlings C., Ramchurren N., et al. Discovery of T cell antigens by high-throughput screening of synthetic minigene libraries. PloS ONE 2012, 7:e29949.
24. Finco O., Frigimelica E., Buricchi F., Petracca R., Galli G., Faenzi E., et al. Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:9969-9974.
25. Jing L., McCaughey S.M., Davies D.H., Chong T.M., Felgner P.L., De Rosa S.C., et al. ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans. Journal of Immunological Methods 2009, 347:36-45.
26. Lopez J.E., Beare P.A., Heinzen R.A., Norimine J., Lahmers K.K., Palmer G.H., et al. High-throughput identification of T-lymphocyte antigens from Anaplasma marginale expressed using in vitro transcription and translation. Journal of Immunological Methods 2008, 332:129-141.
27. Coler R.N., Dillon D.C., Skeiky Y.A., Kahn M., Orme I.M., Lobet Y., et al. Identification of Mycobacterium tuberculosis vaccine candidates using human CD4+ T-cells expression cloning. Vaccine 2009, 27:223-233.
28. Jing L., Chong T.M., Byrd B., McClurkan C.L., Huang J., Story B.T., et al. Dominance and diversity in the primary human CD4 T cell response to replication-competent vaccinia virus. Journal of Immunology 2007, 178:6374-6386.
29. Wehler T.C., Karg M., Distler E., Konur A., Nonn M., Meyer R.G., et al. Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression. Journal of Immunological Methods 2008, 339:23-37.
30. Valentino M.D., Hensley L.L., Skrombolas D., McPherson P.L., Woolard M.D., Kawula T.H., et al. Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS. Molecular Immunology 2009, 46:1830-1838.
31. Valentino M.D., Maben Z.J., Hensley L.L., Woolard M.D., Kawula T.H., Frelinger J.A., et al. Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets. Immunology 2011, 132:348-360.
32. Turner M.J., Abdul-Alim C.S., Willis R.A., Fisher T.L., Lord E.M., Frelinger J.G. T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes. Journal of Immunological Methods 2001, 256:107-119.
33. Sanderson S., Shastri N. LacZ inducible, antigen/MHC-specific T cell hybrids. International Immunology 1994, 6:369-376.
34. Beauregard K.E., Lee K.D., Collier R.J., Swanson J.A. pH-dependent perforation of macrophage phagosomes by listeriolysin O from Listeria monocytogenes. The Journal of Experimental Medicine 1997, 186:1159-1163.
35. Portnoy D.A., Jacks P.S., Hinrichs D.J. Role of hemolysin for the intracellular growth of Listeria monocytogenes. The Journal of Experimental Medicine 1988, 167:1459-1471.
36. Higgins D.E., Shastri N., Portnoy D.A. Delivery of protein to the cytosol of macrophages using Escherichia coli K-12. Molecular Microbiology 1999, 31:1631-1641.
37. Picard M.D., Cohane K.P., Gierahn T.M., Higgins D.E., Flechtner J.B. High-throughput proteomic screening identifies Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses that provide protection against vaginal challenge. Vaccine 2012, 30:4387-4393.
38. Skoberne M., Cardin R., Lee A., Kazimirova A., Zielinski V., Garvie D., et al. An adjuvanted herpes simplex virus type 2 (HSV-2) subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in guinea pigs. Journal of Virology 2013.
39. Moffitt K.L., Gierahn T.M., Lu Y.J., Gouveia P., Alderson M., Flechtner J.B., et al. T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell host & Microbe 2011, 9:158-165.
40. Li Y., Gierahn T., Thompson C.M., Trzcinski K., Ford C.B., Croucher N., et al. Distinct effects on diversifying selection by two mechanisms of immunity against Streptococcus pneumoniae. PLoS Pathogens 2012, 8:e1002989.
41. Borovkov A., Magee D.M., Loskutov A., Cano J.A., Selinsky C., Zsemlye J., et al. New classes of orthopoxvirus vaccine candidates by functionally screening a synthetic library for protective antigens. Virology 2009, 395:97-113.
42. Tekiel V., Alba-Soto C.D., Gonzalez Cappa S.M., Postan M., Sanchez D.O. Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library. Vaccine 2009, 27:1323-1332.
43. Beltran P.K., Gutierrez-Ortega A., Puebla-Perez A.M., Gutierrez-Pabello J.A., Flores-Valdez M.A., Hernandez-Gutierrez R., et al. Identification of immunodominant antigens of Mycobacterium bovis by expression library immunization. Veterinary Journal 2011, 190:181-183.
44. Barry M.A., Howell D.P., Andersson H.A., Chen J.L., Singh R.A. Expression library immunization to discover and improve vaccine antigens. Immunological Reviews 2004, 199:68-83.
45. Talaat A.M., Stemke-Hale K. Expression library immunization: a road map for discovery of vaccines against infectious diseases. Infection and Immunity 2005, 73:7089-7098.
46. Pulido J., Kottke T., Thompson J., Galivo F., Wongthida P., Diaz R.M., et al. Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma. Nature Biotechnology 2012, 30:337-343.